Catalyst
Slingshot members are tracking this event:
VX-152, VX-440 "triplet" potential Phase II efficacy data in hetero CF expected in early 2017
Do you think this event is important to the companies below? How will it affect their stock price?
| Related Companies | Importance
|
Impact on Stocks
|
||||
|---|---|---|---|---|---|---|
| VRTX | Community voting in process | |||||
Slingshot Insights Explained
Catalyst Date
Occurred on:
Jul 18, 2017
Occurred Source:
http://investors.vrtx.com/releasedetail.cfm?ReleaseID=1033559
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
Vx-152, Vx-440, Hetero Cystic Fibrosis
